RhumbLine Advisers’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $838K | Buy |
|
|||||
|
2025
Q1 | $671K | Sell |
|
|||||
|
2024
Q4 | $474K | Buy |
|
|||||
|
2024
Q3 | $622K | Sell |
|
|||||
|
2024
Q2 | $988K | Buy |
|
|||||
|
2024
Q1 | $1.45M | Buy |
|
|||||
|
2023
Q4 | $1.64M | Sell |
|
|||||
|
2023
Q3 | $1.56M | Buy |
|
|||||
|
2023
Q2 | $3.54M | Sell |
|
|||||
|
2023
Q1 | $3.6M | Buy |
|
|||||
|
2022
Q4 | $3.21M | Buy |
|
|||||
|
2022
Q3 | $3.23M | Buy |
|
|||||
|
2022
Q2 | $2.49M | Buy |
|
|||||
|
2022
Q1 | $1.4M | Sell |
|
|||||
|
2021
Q4 | $2.04M | Buy |
|
|||||
|
2021
Q3 | $2.12M | Sell |
|
|||||
|
2021
Q2 | $2.96M | Sell |
|
|||||
|
2021
Q1 | $4.15M | Sell |
|
|||||
|
2020
Q4 | $4.98M | Buy |
|
|||||
|
2020
Q3 | $3.46M | Sell |
|
|||||
|
2020
Q2 | $2.39M | Buy |
|
|||||
|
2020
Q1 | $1.47M | Sell |
|
|||||
|
2019
Q4 | $3.75M | Buy |
|
|||||
|
2019
Q3 | $7.12M | Sell |
|
|||||
|
2019
Q2 | $9.34M | Buy |
|
|||||
|
2019
Q1 | $7.74M | Buy |
|
|||||
|
2018
Q4 | $4.49M | Sell |
|
|||||
|
2018
Q3 | $6.83M | Sell |
|
|||||
|
2018
Q2 | $7.71M | Buy |
|
|||||
|
2018
Q1 | $6.6M | Buy |
|
|||||
|
2017
Q4 | $6.35M | Sell |
|
|||||
|
2017
Q3 | $2.64M | Buy |
|
|||||
|
2017
Q2 | $3.28M | Buy |
|
|||||
|
2017
Q1 | $2.67M | Buy |
|
|||||
|
2016
Q4 | $1.84M | Buy |
|
|||||
|
2016
Q3 | $1.33M | Buy |
|
|||||
|
2016
Q2 | $733K | Buy |
|
|||||
|
2016
Q1 | $490K | Buy |
|
|||||
|
2015
Q4 | $789K | Buy |
|
|||||
|
2015
Q3 | $514K | Buy |
|
|||||
|
2015
Q2 | $848K | Buy |
|